Atlas Trials

Biomarker Assessment of Glutamatergic Target Engagement

Clinical trial NCT02134951 · COMPLETED

Trial details

NCT number
NCT02134951
Sponsor
New York State Psychiatric Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Healthy Controls
Start date
2014-05-01
Primary completion
2015-10-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.